<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13D
Under the Securities Exchange Act of 1934
(Amendment No. 3 )*
BOVIE MEDICAL CORPORATION
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
10211F 10 0
--------------------------
(CUSIP Number)
Mr. Eric Rainer Bashford Irwin A. Kishner, Esq.
2689 Strang Boulevard Herrick, Feinstein LLP
Yorktown Heights, New York 10598 2 Park Avenue
Tel.: (914) 572-4327 New York, New York 10016
Tel.: (212) 592-1400
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications)
April 12, 2000
------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box / /.
*The remainder of this cover page shall be filed out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following page(s))
Page 1 of 4 Pages
<PAGE>
- --------------------------------------------------------------------------------
CUSIP NO. 10211F100 13D Page 2 of 4 Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Eric Rainer Bashford Charitable Remainder Unitrust
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) / /
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
779,000
-------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY -0-
OWNED BY -------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 779,000
WITH -------------------------------------------------
10 SHARED DISPOSITIVE POWER
-0-
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
779,000
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* / /
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.59%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
- --------------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION
<PAGE>
Page 3 of 4 Pages
PART II TO SCHEDULE 13D
This statement constitutes Amendment No. 3 to the statement on Schedule
13D filed with the Securities and Exchange Commission on February 19, 1998 (the
"Original Statement"). All defined terms hereunder have the meanings set forth
in the Original Statement. This Amendment No. 3 reflects certain material
changes in the information set forth in the Original Statement, as amended as of
March 10, 1999 and as of March 16, 2000, as follows:
Item 1. Security and Issuer
-------------------
Shares of Common Stock
Bovie Medical Corporation
734 Walt Whitman Road
Suite 207
Melville, New York 11747
(hereinafter, the "Issuer")
------
Item 5. Interest in Securities of the Issuer
------------------------------------
(a) Prior to April 12, 2000, the Trust was the beneficial
owner of 904,000 shares of Common Stock of the Issuer
(the "Trust Shares"), representing 6.49% of the
Issuer's Common Stock. The Trust sold 125,000 of the
Trust Shares described in item 5(c) below.
(c) The Trust sold 125,000 shares of the Issuer's Common
Stock for cash in a private securities transaction at
a price per share equal to $0.16.
Item 6. Contracts, Arrangements, Understandings of Relationships With Respect
to Securities of the Issuer
---------------------------------------------------------------------
None.
Item 7. Exhibits
--------
None.
<PAGE>
Page 4 of 4 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
By: /s/ Eric Rainer Bashford
- ------------------------------------ -----------------------------
Date Eric Rainer Bashford
